1. Home
  2. PAHC vs ABCL Comparison

PAHC vs ABCL Comparison

Compare PAHC & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • ABCL
  • Stock Information
  • Founded
  • PAHC 1946
  • ABCL 2012
  • Country
  • PAHC United States
  • ABCL Canada
  • Employees
  • PAHC N/A
  • ABCL N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • PAHC Health Care
  • ABCL Health Care
  • Exchange
  • PAHC Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • PAHC 812.1M
  • ABCL 818.2M
  • IPO Year
  • PAHC 2014
  • ABCL 2020
  • Fundamental
  • Price
  • PAHC $20.82
  • ABCL $2.97
  • Analyst Decision
  • PAHC Sell
  • ABCL Buy
  • Analyst Count
  • PAHC 4
  • ABCL 3
  • Target Price
  • PAHC $20.50
  • ABCL $8.00
  • AVG Volume (30 Days)
  • PAHC 183.3K
  • ABCL 3.2M
  • Earning Date
  • PAHC 02-05-2025
  • ABCL 02-18-2025
  • Dividend Yield
  • PAHC 2.88%
  • ABCL N/A
  • EPS Growth
  • PAHC N/A
  • ABCL N/A
  • EPS
  • PAHC 0.43
  • ABCL N/A
  • Revenue
  • PAHC $1,046,762,000.00
  • ABCL $32,962,000.00
  • Revenue This Year
  • PAHC $27.25
  • ABCL N/A
  • Revenue Next Year
  • PAHC $14.13
  • ABCL $36.56
  • P/E Ratio
  • PAHC $48.45
  • ABCL N/A
  • Revenue Growth
  • PAHC 7.17
  • ABCL N/A
  • 52 Week Low
  • PAHC $10.04
  • ABCL $2.34
  • 52 Week High
  • PAHC $25.98
  • ABCL $5.62
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 42.91
  • ABCL 50.75
  • Support Level
  • PAHC $19.74
  • ABCL $2.81
  • Resistance Level
  • PAHC $21.82
  • ABCL $3.09
  • Average True Range (ATR)
  • PAHC 0.75
  • ABCL 0.20
  • MACD
  • PAHC 0.08
  • ABCL -0.02
  • Stochastic Oscillator
  • PAHC 51.43
  • ABCL 30.28

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: